Tests:Alpha Fetoprotein, Tumor Marker

From Taranaki Lab Manual
Revision as of 09:00, 17 January 2025 by Kasey Ali Glennie (Kgl005) (talk | contribs) (Created page with "{| class="wikitable" ! colspan="2" | === Overview === |- |Department |Biochemistry  |- |Test Code |TAFP |- |Synonyms |Tumour Marker (AFP) AFP (tumour marker) |- |Turnaround Time |1 hour to 3 days. |- ! colspan="2" |''Specimen Requirements'' |- |Specimen Type | |- |Preferred |7 mL Plain <span style="background:#e30022"> red-top </span> |- |Acceptable | |- |Pediatric Requirements |Blood 0.5 mL Plain   |- ! colspan="2" |''Aliquot Requirements'' |- |Sample T...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Tests:Alpha Fetoprotein, Tumor Marker
Jump to navigation Jump to search

Overview

Department Biochemistry 
Test Code TAFP
Synonyms Tumour Marker (AFP)

AFP (tumour marker)

Turnaround Time 1 hour to 3 days.
Specimen Requirements
Specimen Type
Preferred 7 mL Plain red-top
Acceptable
Pediatric Requirements Blood 0.5 mL Plain  
Aliquot Requirements
Sample Type
Minimum Volume 200 µL Serum 
Aliquot Transportation
Stability – Add test
Clinical Information
Reference Intervals 0 - 16 µg/L (non-pregnant) 

See comment  

Test Method Ci8200 analyser, Abbott Reagent. 
Advanced Notice Not Required  
Comments
This test is useful as a tumour marker and as a safe and effective supplement to the management of patients undergoing treatment for non-seminomatous testicular cancer and

certain germ cell cancers, or for patients being monitored after therapy is complete. The test is NOT a screening test for cancer. 

The test is NOT intended as a screen for neural tube defects.

For the serial monitoring of tumours, tumour markers should be tested in the same laboratory.